Aballe, Bao-as E.
HRN: 16-45-29 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/16/2022
CEFTRIAXONE 1G (VIAL)
06/16/2022
06/23/2022
IVTT
2g
OD
CAP-HR, CHF FC 4, Presumptive PTB
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes